Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...
Zymeworks achieves $14M milestone from GSK
Zymeworks (ZYME) announced achievement of a $14M cash research milestone from GSK (GSK) associated with a clinical milestone. “In April 2016, ...
Nasdaq2d
Zymeworks Receives $14 Million Cash Research Milestone Payment From GSK
(RTTNews) - Zymeworks Inc. (ZYME), Wednesday announced that the company has received a cash research milestone payment of $14 million from GSK plc (GSK) associated with a previous milestone.
The National Law Review2d
Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
In May 2019, this agreement was expanded to provide GSK access to Zymeworks’ unique heavy-light chain pairing technology under the Azymetric™ platform. Under the terms of this expanded ...
manilatimes2d
Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
In May 2019, this agreement was expanded to provide GSK access to Zymeworks' unique heavy-light chain pairing technology under the Azymetric™ platform. Under the terms of this expanded collaboration ...
Zymeworks Inc.: Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics ...
Zymeworks achieves $14M milestone under GSK deal
Zymeworks (NASDAQ:ZYME) said it has achieved a $14M cash research milestone through its collaboration with GSK (GSK). Under ...